• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Biopsy visualization unit gets nod

Article

Ultrasound peripheral developer EchoCath received Food and DrugAdministration 510(k) approval in September for its ColorMarkdevice for improving needle visualization during ultrasound-guidedbiopsy. The device consists of a vibrating clip attached to a

Ultrasound peripheral developer EchoCath received Food and DrugAdministration 510(k) approval in September for its ColorMarkdevice for improving needle visualization during ultrasound-guidedbiopsy.

The device consists of a vibrating clip attached to a biopsyneedle. The vibration creates a phase shift that shows up as amultihued stripe on color-flow Doppler scanners. EchoCath unveiledthe technology at the American Institute of Ultrasound in Medicinemeeting in March (SCAN 5/19/93).

ColorMark could aid the transition of biopsy procedures fromCT to ultrasound, as well as increase the accuracy of fine-needleaspiration biopsy, the manufacturer said. EchoCath is developinga ColorMark system for the Bard biopsy gun.

The firm is gearing up production of ColorMark devices andintends to begin shipping product in the first quarter of nextyear.

BRIEFLY NOTED:

  • President Clinton formally introduced health-care reformlegislation in Congress last week. In introducing the package,Clinton urged Congress to pass health-care reform by the end ofnext year. Copies of the plan, as well as an executive summaryof the proposal, are available for $45 by contacting the GovernmentPrinting Office at 202/783-3238.

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.